CRP and metabolic syndrome: The acute-phase reactants C-reactive proteins (CRP, p < 0.001) and high-sensitivity CRP (hs-CRP, p < 0.001) are commonly used to monitor inflammation and are strongly associated with metabolic syndrome, atherosclerotic cardiovascular disease, and T2D.